While statins can reduce LDL levels and ASCVD events, high Lp(a) poses an independent risk that will need attention, too.
Leerink Partners analyst Thomas Smith has reiterated their bullish stance on TRML stock, giving a Buy rating yesterday. Thomas Smith’s ...
Results demonstrated the mean total medical costs per patient per year decreased significantly after patients began ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback